FundedIQ
Biotechnology

Eris Biotech: Funding, Investors & Team (Oct 2026)

Eris Biotech focuses on developing hypoxia-activated prodrugs (HAPs) to treat solid tumors in the biotech industry.

www.erisbio.com LinkedIn American Fork, United States 1-10 employees
Biopharma Biotechnology Medical Wellness
Total raised
$500k
Rounds
1
Latest
Undisclosed round
Mar 2024

Eris Biotech has raised $500k across 1 funding round on record, the most recent an undisclosed round of $500k announced in Mar 2024.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Eris Biotech Company Profile and Key Stats

Total funding raised
$500k
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$500k in Mar 2024
Employees
1-10
reported band
Headquarters
American Fork, United States

Latest funding round on record: Mar 2024.

Eris Biotech Funding Rounds

Date
Round
Amount
Undisclosed round
$500k

Eris Biotech Founders and Leadership Team

Name
Role
Contact
Rachel Brog Garlick
Founder
Locked

Contact details for the Eris Biotech team: 1 of 1 has an email address on file.

Start 14-day free trial →

Eris Biotech Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

Eris Biotech's latest round of $500k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Eris Biotech in Biotechnology and American Fork

Companies Similar to Eris Biotech

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Eris Biotech Funding FAQs

What does Eris Biotech do?

Eris Biotech focuses on developing hypoxia-activated prodrugs (HAPs) to treat solid tumors in the biotech industry.

How much funding has Eris Biotech raised?

Eris Biotech has raised $500k across 1 round on record. The most recent is an undisclosed round of $500k announced in Mar 2024.

When did Eris Biotech last raise funding?

Eris Biotech's most recent funding round on record is an undisclosed round of $500k, announced in Mar 2024.

Who founded Eris Biotech?

FundedIQ lists Rachel Brog Garlick (Founder) at Eris Biotech.

Where is Eris Biotech headquartered?

Eris Biotech is based in American Fork, Utah, United States.

How many employees does Eris Biotech have?

Eris Biotech is in the 1-10 employee band.

How does Eris Biotech's funding compare to other Biotechnology startups?

Eris Biotech's latest round of $500k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Eris Biotech Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Eris Biotech is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.